XU Yu-yan, ZHU Liu-yan, SHAO Jie
徐钰艳, 朱柳燕, 邵洁
|  Michalus I,Rusińska A. Rare,genetically conditioned forms of rickets:Differential diagnosis and advances in diagnostics and treatment[J]. Clin Genet,2018,94(1) :103-114.
 Lambert AS,Linglart A. Hypocalcaemic and hypophosphatemic rickets[J]. Best Pract Res Clin Endocrinol Metab,2018,32(4):455-476.
 Robinson ME,AlQuorain H,Murshed M,et al. Mineralized tissues in hypophosphatemic rickets[J]. Pediatr Nephrol,2020,35(10):1843-1854.
 Goldsweig BK,Carpenter TO. Hypophosphatemic rickets:lessons from disrupted FGF23 control of phosphorus homeostasis[J]. Curr Osteoporos Rep,2015,13(2):88-97.
 Blaine J,Chonchol M,Levi M. Renal control of calcium,phosphate,and magnesium homeostasis[J]. Clin J Am Soc Nephrol,2015,10(7):1257-72.
 Kinoshita Y,Fukumoto S. X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases:prospect for new treatment[J]. Endocr Rev,2018,39(3):274-291.
 Christov M, Jüppner H. Phosphate homeostasis disorders[J]. Best Pract Res Clin Endocrinol Metab,2018,32(5):685-706.
 Bergwitz C,Miyamoto KI. Hereditary hypophosphatemic rickets with hypercalciuria:pathophysiology,clinical presentation,diagnosis and therapy[J]. Pflugers Arch,2019,471(1):149-163.
 Fuente R, Gil-Peña H, Claramunt-Taberner D,et al. X-linked hypophosphatemia and growth[J]. Rev Endocr Metab Disord,2017,18(1):107-115.
 Carpenter TO,Shaw NJ,Portale AA,et al.Rickets[J].Nat Rev Dis Primers,2017,3:17101.
 Menon LP,Weinstein RS.Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets:A review of the role of iron.[J].Bone,2020,131:115-137.
 Haffner D,Emma F,Eastwood DM,et al.Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia[J].Nat Rev Nephrol,2019,15(7):435-455.
 Rafaelsen S,Johansson S,Raeder H,et al.Hereditary hypophosphatemia in Norway:a retrospective population-based study of genotypes,phenotypes,and treatment complications[J].Eur J Endocrinol,2016,174(2):125-136.
 Gordon RJ,Levine MA.Burosumab treatment of children with X-linked hypophosphataemic rickets[J].Lancet,2019,393(10189):2364-2366.
 Bitzan M,Goodyer PR.Hypophosphatemic rickets[J].Pediatr Clin North Am,2019,66(1):179-207.
 Farrow EG,Yu X,Summers LJ,etal.Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice[J]. Proc Natl Acad Sci U S A,2011,108(46):1146-1155.
 Imel EA,Liu Z,Coffman M,et al. Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets[J]. J Bone Miner Res,2020,35(2):231-238
 Razali NN,Hwu TT,Thilakavathy K.Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets[J].J Pediatr Endocrinol Metab,2015,28(9-10):1009-1017.
 Oheim R,Zimmerman K,Maulding ND,et al. Human heterozygous ENPP1 deficiency is associated with early onset osteoporosis,a phenotype recapitulated in a mouse model of enpp1 deficiency[J]. J Bone Miner Res,2020,35(3):528-539.
 Kotwal A,Ferrer A,Kumar R,et al. Clinical and biochemical phenotypes in a family with ENPP1 mutations[J]. J Bone Miner Res,2020,35(4):662-670.
 Asch S,Sugarman JL. Epidermal nevus syndromes:New insights into whorls and swirls[J]. Pediatric Dermatol,2018,35:21-29.
 Avitan-Hersh E,Tatur S,Indelman M,et al. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23[J]. J Clin Endocrinol Metab,2014,99(1):132-136.
 Park PG,Park E,Hyun HS,et al. Cutaneous skeletal hypophosphatemia syndrome in association with a mosaic HRAS mutation[J]. Ann Clin Lab Sci,2018,48(5):665-669.
 Pal R,Dutta P,Mukherjee KK,et al. Acromegaly with hypophosphataemia:McCune-Albright syndrome[J]. BMJ Case Rep,2017:bcr2017221827.
 Obo T,Koriyama N,Tokito A,et al. Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23:a case report[J]. J Med Case Rep,2020,14(1):56.
 Rothenbuhler A,Schnabel D,Hogler W,et al.Diagnosis,treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)[J].Metabolism,2020,103s:153892.
 Chesher D,Oddy M,Darbar U,et al.Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations[J].J Inherit Metab Dis,2018,41(5):865-876.
 Vega RA,Opalak C,Harshbarger RJ,et al.Hypophosphatemic rickets and craniosynostosis:a multicenter case series[J].J Neurosurg Pediatr,2016,17(6):694-700.
 Rothenbuhler A,Fadel N,Debza Y,et al.High incidence of cranial synostosis and chiari I malformation in children with X-Linked hypophosphatemic rickets (XLHR)[J].J Bone Miner Res,2019,34(3):490-496.
 Brachet C,Mansbach AL,Clerckx A,et al.Hearing loss is part of the clinical picture of ENPP1 loss of function mutation[J].Horm Res Paediatr,2014,81(1):63-66.
 Lempicki M,Rothenbuhler A,Merzoug V,et al.Magnetic resonance imaging features as surrogate markers of X-Linked hypophosphatemic rickets activity.[J].Horm Res Paediatr,2017,87(4):244-253.
 Keskin M,Savas-Erdeve S,Sagsak E,et al.Risk factors affecting the development of nephrocalcinosis,the most common complication of hypophosphatemic rickets[J].J Pediatr Endocrinol Metab,2015,28(11-12):1333-1337.
 Insogna KL,Briot K,Imel EA,et al.A Randomized,double-blind,placebo-controlled,phase 3 trial evaluating the efficacy of burosumab,an anti-FGF23 antibody,in adults with X-Linked Hypophosphatemia:Week 24 primary analysis[J].J Bone Miner Res,2018,33(8):1383-1393.
 Lamb YN.Burosumab:First global approval[J].Drugs,2018,78(6):707-714.
 Kapelari K,Kohle J,Kotzot D,et al. Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets[J].J Clinton Endocrinol Metab,2015,100(9):3388-3392.
 Meyerhoff N,Haffner D,Staude H,et al.Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets[J].Pediatr Nephrol,2018,33(3):447-456.
 Sharkey MS,Grunseich K,Carpenter TO.Contemporary medical and surgical management of X-linked hypophosphatemic rickets[J].J Am Acad Orthop Surg,2015,23(7):433-442.
|||HUANG Li-hong, SHI Hui-ling, LIN Yao, FU Li-ying, LIU Ying, SHI Liang-sun. Past changes and future trend of low weight rate of children under 5 years old in Haikou [J]. Chinese Journal of Child Health Care, 2022, 30(9): 956-959.|
|||LIU Yan, LI Zhi-hui, KONG Yan, YIN Chun-lan, YU Gui-ling. Mediating and moderating effects of appetite traits and temperament of infants and young children on the association between positive feeding behaviors and body mass index [J]. Chinese Journal of Child Health Care, 2022, 30(9): 965-969.|
|||JIANG Xue, GAO Jian, HONG Ze, ZHOU Wen-di. Clinical study on treatment of obese children with nonalcoholic fatty liver disease by vitamin D [J]. Chinese Journal of Child Health Care, 2022, 30(9): 970-974.|
|||ZHANG Yan. Body composition analysis and its correlation with serum uric acid in children aged 8 - 11 years in Taiyuan [J]. Chinese Journal of Child Health Care, 2022, 30(9): 1005-1009.|
|||DAI Qian-qian, LOU Hai-qin, LIU Wei-wei, CHEN Si-han, SHAN Ling-ling, XU Zhan-bin, ZHANG Hui-ying. Current situation and influencing factors of urban preschool children's neglect in Nantong city [J]. Chinese Journal of Child Health Care, 2022, 30(9): 1010-1013.|
|||WANG An-yun, LIU Zhi-chen, FAN Jing-yi. Emotional and behavior problems and dietary behavior problems in preschool children with autism spectrum disorder [J]. Chinese Journal of Child Health Care, 2022, 30(9): 1019-1023.|
|||LEI Jun, ZHOU Xiao-yan, HE Jian-yong, JIN Hai-ju, LIU Li-fang, YE Piao. Correlation between body mass index and physical health of preschool children in Lishui City [J]. Chinese Journal of Child Health Care, 2022, 30(9): 1033-1036.|
|||CHEUNG Hin-Tat, LI Xue, LIAO Min. Reliability and validity of grammar subscale of Children's Language Development Scale [J]. Chinese Journal of Child Health Care, 2022, 30(8): 822-827.|
|||GUO Fu-rong, ZHOU Mei-xiang, ZHOU Peng, CHEN Wei. Mediating role of home literacy environment between parental educationand children's vocabulary ability [J]. Chinese Journal of Child Health Care, 2022, 30(8): 828-833.|
|||LIU Zi-zi, XU Xiao-yu, PAN Ning, JIN Yu-ying, GUO Xu-ning, LI Xiu-hong. Study on the correlation between cognitive ability and learning disability in children [J]. Chinese Journal of Child Health Care, 2022, 30(8): 834-838.|
|||CAI Ting-ting, MA Bing-xiang, KONG Ya-min, ZHANG Ying-dan, ZHANG Xiao-meng, GU Shuang-long. Research progress in gestures defect in children with autism spectrum disorder [J]. Chinese Journal of Child Health Care, 2022, 30(8): 860-864.|
|||SHEN Shi-fang, SHAO Jie. Family parenting and early childhood language development [J]. Chinese Journal of Child Health Care, 2022, 30(8): 865-868.|
|||WU Man-hong, DENG Xue-mei, LIN Hua-zhao, YU Chu-lan, ZENG Liu-yuan, YANG Yun. Results of Gesell Developmental Scale of 2- to 3- year-old children with autism spectrum disorder or developmental language disorder [J]. Chinese Journal of Child Health Care, 2022, 30(8): 895-899.|
|||YOU Hai-zhen, ZHOU Yi-fang, XIE Jing, JIN Zhi-juan, WANG Guang-hai, SUN Ke-xing. Correlation between serum vitamin D and tic disorder [J]. Chinese Journal of Child Health Care, 2022, 30(8): 904-907.|
|||DU Wen-ge, WU Guo-bao, YE Gang, GUO Yong-song. Correlation of knowledge, belief and behavior regarding adolescence with psychological resilience of Uygur left-behind primary and middle school students in Kashgar rural area [J]. Chinese Journal of Child Health Care, 2022, 30(8): 920-923.|